您要查找的是不是：
- Angiotensin enzemy inhibitor 血管紧张素转化酶抑制剂
- Angiotensin enzemy converting inhibitor 血管紧张素转化酶抑制剂
- Conclusion Administering angiotensin converting enzyme inhibitor orally may be effective for neurally mediated syncope. 结论提示血管紧张素转化酶抑制剂可能是防治神经心原性晕厥发作的一类有效药物。
- Mouse Angiotensin converting enzyme，ACE Elis... 小鼠血管紧张素转化酶（ACE）试剂盒；
- Objective To observe the effect of urokinase(UK) combined with angiotensin converting enzyme inhibitor (ACEI) on IgA nephropathy(IgAN). 目的 观察联合应用尿激酶(UK)和血管紧张素转换酶抑制剂(ACEI)苯那普利治疗IgA肾病(IgAN)的效果。
- Is Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Combination Therapy Better Than Monotherapy and Safe in Patients With CKD? 血管紧张素转化酶抑制剂和血管紧张素受体拮抗剂联合用药治疗CKD是否比单药应用要好？
- CL was a potent inhibitor of Ca 2+ ,Mg 2+ ATPase. 马桑内酯是Ca2＋，Mg2＋?ATP酶的强力抑制剂。
- Usually, Clr is binding to C1INH (Cl inhibitor). 补体组分C1r含有两个CUB结构域，一个EGF结构域和一个丝氨酸蛋白酶结构域，是一种丝氨酸蛋白酶原。
- Mouldproof wall paper, join mould inhibitor. 防霉墙纸，加入防霉剂。
- Rat Tissue factor pathway inhibitor,TFPI ... 大鼠组织因子途径抑制物(TFPI)ELISA Kit；
- Rabbit Tissue factor pathway inhibitor，TFPI... 兔组织因子途径抑制物（TFPI）试剂盒；
- Human Tissue factor pathway inhibitor，TFPI ... 人组织因子途径抑制物（TFPI）试剂盒；
- Argatroban is a new direct thrombin inhibitor. 阿加曲班是一种新型的直接凝血酶抑制药。
- Less than one-third of subjects were receiving an angiotensin converting enzyme inhibitor at baseline, although this rose to around 40% by the end of follow-up. 不到三分之一的受试者接受一种血管紧张素转换酶抑制剂作为基础用药，尽管在结束随访时接近40%25。
- To investigate the effects of perindopril, an angiotensin converting enzyme inhibitor, on mean pulmonary arterial pressure(mPAP) and pulmonary vascular remodeling. 目的探讨培哚普利对常压慢性缺氧高二氧化碳性肺动脉高压及肺血管重建的影响。
- Lurgiuses have used undisclosed promoter and corrosion inhibitor. 鲁奈公司采用了未公开的活性剂和防蚀剂。
- It up-stimulate the cascade of eents leading to angiotensin II formation. 而我们知道肾素是可以正向刺激一系列的反应从而导致血管紧张素II的形成的。
- Angiotensin receptor (ATR) mRNA expression of VSMC was measured by RT PCR. RT PCR检测VSMC血管紧张素受体 (ATR)mRNA表达。
- There is a strong evidence about the effect of angiotensin receptor blockers. 通过这些临床试验得到了强有力的证据证明血管紧张素受体阻滞剂的疗效。
- Lurgiuses has used undisclosed promoter and corrosion inhibitor. 鲁奈公司采用了未公开的活性剂和防蚀剂。
